Trial
NCT03605654
Cellular Immunotherapy in Recipients of Human Leukocyte Antigen (HLA)-Mismatched, Living Donor Kidney Transplants
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Medeor Therapeutics, Inc.
Collaborators
—
Condition
Kidney Transplant Rejection
Intervention
MDR-102
Why stopped
Lack of funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-06-07